Morgan Stanley Dr Reddys Laboratories LTD Call Options Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RDY
# of Institutions
245Shares Held
23.1MCall Options Held
12.7KPut Options Held
6.1K-
Robeco Institutional Asset Management B.V.2.07MShares$29.9 Million0.33% of portfolio
-
Royal Bank Of Canada Toronto, A62MShares$28.9 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.95MShares$28.2 Million0.25% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$26.1 Million0.0% of portfolio
-
Aikya Investment Management LTD London, X01.09MShares$15.7 Million9.6% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.4B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...